These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7435677)
1. Combined monoamine oxidase inhibitor-tricyclic antidepressant treatment: a pilot study. White K; Pistole T; Boyd JL Am J Psychiatry; 1980 Nov; 137(11):1422-5. PubMed ID: 7435677 [TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trial. Razani J; White KL; White J; Simpson G; Sloane RB; Rebal R; Palmer R Arch Gen Psychiatry; 1983 Jun; 40(6):657-61. PubMed ID: 6342565 [TBL] [Abstract][Full Text] [Related]
3. Electrocardiographic effects of tranylcypromine vs. amitriptyline. White K; O'Leary J; Razani J; Rebal R; Palmer R J Clin Psychiatry; 1983 Mar; 44(3):91-3. PubMed ID: 6833194 [TBL] [Abstract][Full Text] [Related]
4. Treatment of melancholia with tranylcypromine. McGrath PJ; Quitkin FM; Harrison W; Stewart JW Am J Psychiatry; 1984 Feb; 141(2):288-9. PubMed ID: 6691499 [TBL] [Abstract][Full Text] [Related]
5. Brofaromine in non-endogenous major depressed inpatients--results of a preliminary dose-finding trial versus tranylcypromine. Volz HP; Heimann H; Bellaire J; Laux G; Möller HJ Pharmacopsychiatry; 1994 Jul; 27(4):152-8. PubMed ID: 7972347 [TBL] [Abstract][Full Text] [Related]
6. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression. Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263 [TBL] [Abstract][Full Text] [Related]
7. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial. Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406 [TBL] [Abstract][Full Text] [Related]
8. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors]. von Oefele K; Grohmann R; Hippius H; Rüther E Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260 [No Abstract] [Full Text] [Related]
9. The efficacy and tolerability of combined antidepressant treatment in different depressive subgroups. O'Brien S; McKeon P; O'Regan M Br J Psychiatry; 1993 Mar; 162():363-8. PubMed ID: 8453432 [TBL] [Abstract][Full Text] [Related]
10. Tranylcypromine versus imipramine in anergic bipolar depression. Himmelhoch JM; Thase ME; Mallinger AG; Houck P Am J Psychiatry; 1991 Jul; 148(7):910-6. PubMed ID: 2053632 [TBL] [Abstract][Full Text] [Related]
11. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of lithium-tranylcypromine treatment in refractory depression. Price LH; Charney DS; Heninger GR Am J Psychiatry; 1985 May; 142(5):619-23. PubMed ID: 3920923 [TBL] [Abstract][Full Text] [Related]
13. The pharmacological treatment of delusional depression. Spiker DG; Weiss JC; Dealy RS; Griffin SJ; Hanin I; Neil JF; Perel JM; Rossi AJ; Soloff PH Am J Psychiatry; 1985 Apr; 142(4):430-6. PubMed ID: 3883815 [TBL] [Abstract][Full Text] [Related]
15. Blood pressure effects of tranylcypromine when prescribed singly and in combination with amitriptyline. O'Brien S; McKeon P; O'Regan M; O'Flaherty A; Patel R J Clin Psychopharmacol; 1992 Apr; 12(2):104-9. PubMed ID: 1573032 [TBL] [Abstract][Full Text] [Related]
16. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. Feighner JP J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions? Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567 [TBL] [Abstract][Full Text] [Related]
18. Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression. Thase ME; Mallinger AG; McKnight D; Himmelhoch JM Am J Psychiatry; 1992 Feb; 149(2):195-8. PubMed ID: 1734739 [TBL] [Abstract][Full Text] [Related]
19. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression. Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026 [TBL] [Abstract][Full Text] [Related]
20. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Goodwin FK; Prange AJ; Post RM; Muscettola G; Lipton MA Am J Psychiatry; 1982 Jan; 139(1):34-8. PubMed ID: 7055275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]